India to United States: Cephalexin Export Trade Route

The India to United States Cephalexin corridor is one of India's established pharmaceutical export routes, with 970 shipments documented worth a combined $264.9M USD. The route is dominated by ALKEM LABORATORIES LIMITED, which alone accounts for roughly 88% of all export value, reflecting the consolidated nature of India's cephalexin manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $273.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with cephalexin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 22.0%, placing it at rank #9 among India's top cephalexin export destinations globally.

On the import side, key buyers of Indian cephalexin in United States include ASCEND LABORATORIES, LLC C/O UPS, ASCEND LABORATORIES,LLC, ASCEND LABORATORIES, LLC., and 34 others. ASCEND LABORATORIES, LLC C/O UPS is the single largest importer with 2 shipments valued at $98.0M USD.

India's cephalexin exports to United States are driven primarily by a handful of large-scale manufacturers. ALKEM LABORATORIES LIMITED with 450 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALKEM LABORATORIES LIMITED, LUPIN LIMITED, AUROBINDO PHARMA LTD — together account for 99% of total trade value on this route. The average shipment value of $273.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical productscephalexin 250mgcapsules (500s)anda ndc no67877022005 each capsules contains: cephalexin monohyd and cephalexin 500mg capsules (each capsulescontains : cephalexin monohydrate eq.tocephalexin 500mg) - 3103 pac x 500's, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ASCEND LABORATORIES, LLC C/O UPS is the largest importer with 2 shipments worth $98.0M USD — representing 37% of all cephalexin imports from India on this route. A total of 37 buyers are active on this corridor.